Kidney Cancer
461
59
85
255
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
89 trials with published results (19%)
Research Maturity
255 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.6%
49 terminated out of 461 trials
83.9%
-2.6% vs benchmark
8%
39 trials in Phase 3/4
35%
89 of 255 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 255 completed trials
Clinical Trials (461)
Integrated Cancer Repository for Cancer Research
TDM for Optimized Outcome in Patients With mRCC.
Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial
Linking In With Advice and Supports for Men Impacted by Metastatic Cancer
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies
Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Rein 3D PRINT MECHANICS
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
Study of Post-operative Complications After Laparoscopic Outpatient Nephrectomy
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations